Philippe Menu, Chief Medical Officer at SOPHiA GENETICS, sold SOPH on Sep 14, 2026

Data as of Oct 16

▼ SELL$39.4K5,000 shares at $7.88Philippe Menu Chief Medical OfficerSOPH SOPHiA GENETICS SA

Watch SOPH

Traded: Sep 14, 2026
Disclosed: Sep 16, 2026
Filed: 2 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

SOPHSimilar stocks (S&P 500 (SPY)), rebased to SOPH's price on the disclosure day

SOPH since disclosure

−15.6%

after the sale

Similar stocks (SPY) since disclosure

+1.2%

S&P 500 (SPY)

Change in closing price from Sep 16, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

See every trade on SOPH →